Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: An Update of the 2007 Comparative Effectiveness Review [Internet].

Gartlehner G, Hansen RA, Morgan LC, Thaler K, Lux LJ, Van Noord M, Mager U, Gaynes BN, Thieda P, Strobelberger M, Lloyd S, Reichenpfader U, Lohr KN.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Dec.

2.

Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians.

Gartlehner G, Gaynes BN, Hansen RA, Thieda P, DeVeaugh-Geiss A, Krebs EE, Moore CG, Morgan L, Lohr KN.

Ann Intern Med. 2008 Nov 18;149(10):734-50. Review.

PMID:
19017592
3.

Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review.

Thaler KJ, Morgan LC, Van Noord M, Gaynes BN, Hansen RA, Lux LJ, Krebs EE, Lohr KN, Gartlehner G.

Depress Anxiety. 2012 Jun;29(6):495-505. doi: 10.1002/da.21951. Epub 2012 May 2. Review.

PMID:
22553134
4.

Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.

Banzi R, Cusi C, Randazzo C, Sterzi R, Tedesco D, Moja L.

Cochrane Database Syst Rev. 2015 May 1;(5):CD011681. doi: 10.1002/14651858.CD011681. Review.

PMID:
25931277
5.

Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis.

Gartlehner G, Thieda P, Hansen RA, Gaynes BN, Deveaugh-Geiss A, Krebs EE, Lohr KN.

Drug Saf. 2008;31(10):851-65. Review.

PMID:
18759509
6.

Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis.

Gartlehner G, Hansen RA, Morgan LC, Thaler K, Lux L, Van Noord M, Mager U, Thieda P, Gaynes BN, Wilkins T, Strobelberger M, Lloyd S, Reichenpfader U, Lohr KN.

Ann Intern Med. 2011 Dec 6;155(11):772-85. doi: 10.7326/0003-4819-155-11-201112060-00009. Review.

PMID:
22147715
7.

Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder.

Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS.

Ann Intern Med. 2005 Sep 20;143(6):415-26. Review.

PMID:
16172440
8.

The general and comparative efficacy and safety of duloxetine in major depressive disorder: a systematic review and meta-analysis.

Gartlehner G, Thaler K, Hansen RA, Gaynes BN.

Drug Saf. 2009;32(12):1159-73. doi: 10.2165/11318930-000000000-00000. Review.

PMID:
19916583
9.

Vortioxetine for depression in adults.

Koesters M, Ostuzzi G, Guaiana G, Breilmann J, Barbui C.

Cochrane Database Syst Rev. 2017 Jul 5;7:CD011520. doi: 10.1002/14651858.CD011520.pub2. Review.

PMID:
28677828
10.

Duloxetine versus other anti-depressive agents for depression.

Cipriani A, Koesters M, Furukawa TA, Nosè M, Purgato M, Omori IM, Trespidi C, Barbui C.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD006533. doi: 10.1002/14651858.CD006533.pub2. Review.

11.

[Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].

Favré P.

Encephale. 2012 Feb;38(1):86-96. doi: 10.1016/j.encep.2011.11.003. Epub 2011 Dec 10. Review. French.

PMID:
22381728
12.

Antidepressant treatment for postnatal depression.

Molyneaux E, Howard LM, McGeown HR, Karia AM, Trevillion K.

Cochrane Database Syst Rev. 2014 Sep 11;(9):CD002018. doi: 10.1002/14651858.CD002018.pub2. Review.

PMID:
25211400
13.

Agomelatine versus other antidepressive agents for major depression.

Guaiana G, Gupta S, Chiodo D, Davies SJ, Haederle K, Koesters M.

Cochrane Database Syst Rev. 2013 Dec 17;(12):CD008851. doi: 10.1002/14651858.CD008851.pub2. Review.

PMID:
24343836
14.

Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.

Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, Coghill D, Zhang Y, Hazell P, Leucht S, Cuijpers P, Pu J, Cohen D, Ravindran AV, Liu Y, Michael KD, Yang L, Liu L, Xie P.

Lancet. 2016 Aug 27;388(10047):881-90. doi: 10.1016/S0140-6736(16)30385-3. Epub 2016 Jun 8.

PMID:
27289172
15.

Antidepressants for people with epilepsy and depression.

Maguire MJ, Weston J, Singh J, Marson AG.

Cochrane Database Syst Rev. 2014 Dec 3;(12):CD010682. doi: 10.1002/14651858.CD010682.pub2. Review.

PMID:
25464360
16.

Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update.

Spina E, Santoro V, D'Arrigo C.

Clin Ther. 2008 Jul;30(7):1206-27. Review.

PMID:
18691982
17.

Comparative Effectiveness of Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression [Internet].

Gartlehner G, Hansen RA, Thieda P, DeVeaugh-Geiss AM, Gaynes BN, Krebs EE, Lux LJ, Morgan LC, Shumate JA, Monroe LG, Lohr KN.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2007 Jan.

18.

Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians.

Qaseem A, Snow V, Denberg TD, Forciea MA, Owens DK; Clinical Efficacy Assessment Subcommittee of American College of Physicians.

Ann Intern Med. 2008 Nov 18;149(10):725-33. Erratum in: Ann Intern Med. 2009 Jan 20;150(2):148.

PMID:
19017591
19.
20.

Pharmacological interventions for somatoform disorders in adults.

Kleinstäuber M, Witthöft M, Steffanowski A, van Marwijk H, Hiller W, Lambert MJ.

Cochrane Database Syst Rev. 2014 Nov 7;(11):CD010628. doi: 10.1002/14651858.CD010628.pub2. Review.

PMID:
25379990

Supplemental Content

Support Center